Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-17-049663

SVP & Chief Scientific Officer sold 1,701 shares at $19.32 ($32,863)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Doberstein Stephen K SVP & Chief Scientific Officer 2017-08-16 Sale −1,701 $19.32 $32,863 31,102 D
Open-market sales · 1,701 sh · avg $19.32 · $32,863
Loading xslF345X03/doc4.xml…